Avraham Hochberg

492 total citations
9 papers, 412 citations indexed

About

Avraham Hochberg is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Avraham Hochberg has authored 9 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Surgery. Recurrent topics in Avraham Hochberg's work include Epigenetics and DNA Methylation (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Urinary and Genital Oncology Studies (2 papers). Avraham Hochberg is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Urinary and Genital Oncology Studies (2 papers). Avraham Hochberg collaborates with scholars based in Israel, Canada and Palestinian Territory. Avraham Hochberg's co-authors include Michal Gilon, Imad Matouk, Eli Raveh, Vladimir Sorin, Patricia Ohana, David Halle, Shalva Benjamin, Janet H. Ransom, Donald L. Lamm and Moshe Shalev and has published in prestigious journals such as PLoS ONE, The Journal of Urology and Oncotarget.

In The Last Decade

Avraham Hochberg

9 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Avraham Hochberg Israel	8	303	232	47	44	40	9	412
M. S. Lo Piccolo Italy	10	270 0.9×	174 0.8×	36 0.8×	87 2.0×	39 1.0×	13	473
Genesio Leo Italy	7	188 0.6×	158 0.7×	44 0.9×	91 2.1×	25 0.6×	9	331
Jiantao Xiao China	12	221 0.7×	72 0.3×	42 0.9×	66 1.5×	27 0.7×	16	367
Yinghan Su China	9	204 0.7×	136 0.6×	17 0.4×	71 1.6×	27 0.7×	11	305
K Ashihara Japan	11	200 0.7×	141 0.6×	37 0.8×	139 3.2×	36 0.9×	16	407
Marion Gayral France	7	282 0.9×	204 0.9×	45 1.0×	221 5.0×	43 1.1×	7	479
Kazuki Heishima Japan	13	287 0.9×	222 1.0×	31 0.7×	65 1.5×	20 0.5×	36	453
Ryan C. Chai Australia	12	299 1.0×	91 0.4×	74 1.6×	124 2.8×	51 1.3×	22	486
Daniel Garcia United States	6	276 0.9×	72 0.3×	20 0.4×	160 3.6×	35 0.9×	6	406

Countries citing papers authored by Avraham Hochberg

Since Specialization

Citations

This map shows the geographic impact of Avraham Hochberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avraham Hochberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avraham Hochberg more than expected).

Fields of papers citing papers by Avraham Hochberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avraham Hochberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avraham Hochberg. The network helps show where Avraham Hochberg may publish in the future.

Co-authorship network of co-authors of Avraham Hochberg

This figure shows the co-authorship network connecting the top 25 collaborators of Avraham Hochberg. A scholar is included among the top collaborators of Avraham Hochberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avraham Hochberg. Avraham Hochberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Lavie, Ofer, David Edelman, Tally Levy, et al.. (2017). A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer. Archives of Gynecology and Obstetrics. 295(3). 751–761. 44 indexed citations

Gielchinsky, Ilan, Michal Gilon, Rasha Abu-lail, et al.. (2017). H19 non-coding RNA in urine cells detects urothelial carcinoma: a pilot study. Biomarkers. 22(7). 661–666. 11 indexed citations

Matouk, Imad, David Halle, Eli Raveh, et al.. (2015). The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision. Oncotarget. 7(4). 3748–3765. 107 indexed citations

Feigenberg, Tomer, Ofer N. Gofrit, Galina Pizov, Avraham Hochberg, & Abraham Benshushan. (2013). Expression of the H19 Oncofetal Gene in Premalignant Lesions of Cervical Cancer: A Potential Targeting Approach for Development of Nonsurgical Treatment of High-Risk Lesions. ISRN Obstetrics and Gynecology. 2013. 1–7. 13 indexed citations

Sorin, Vladimir, Patricia Ohana, Tatiana Birman, et al.. (2012). H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer. ISRN Oncology. 2012. 1–7. 28 indexed citations

Hasenpusch, Günther, Manish K. Aneja, Dietrich Reinhardt, et al.. (2011). Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth. PLoS ONE. 6(6). e20760–e20760. 34 indexed citations

Sidi, A., Patricia Ohana, Shalva Benjamin, et al.. (2008). Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin. The Journal of Urology. 180(6). 2379–2383. 111 indexed citations

Elkin, Michael, Reuven Reich, Arnon Nagler, et al.. (1999). Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.. PubMed. 5(8). 1982–8. 61 indexed citations

Gonik, Bernard, Jacob Rachmilewitz, Avraham Hochberg, Ran Goshen, & N DEGROOT. (1994). Induction of Tumor Necrosis Factor and Interleukin‐6 mRNA in Human Cytotrophoblast Cells Exposed to Lipopolysaccharide. Infectious Diseases in Obstetrics and Gynecology. 2(1). 3–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact